CGMP Latanoprost

CGMP Latanoprost
Product Description

Latanoprost is the most widely used prostaglandin for the treatment of elevated intraocular pressure in glaucoma. Latanoprost is manufactured at Cayman Chemical (Ann Arbor, MI, USA) and at Cayman Pharma (Czech Republic). GMP material from both Cayman Chemical and Cayman Pharma, which conforms to the USP, EP, and IP Monographs, is available. Each site maintains a unique DMF; they have been filed with the US FDA, Canada, India, several EU member states and several other countries. Cayman Chemical has been granted CEP.

Cayman Pharma s.r.o

  • CZ
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
Generic APIs producer
Specifications
  • CAS Registry Number
    130209-82-4
  • Details
    USP and Ph. Eur. compliance; Customer-tailored specification
  • Model
    10011176
  • Supplied from
    Czech Republic; United States
  • Measured In
    gram

Cayman Pharma s.r.o

  • CZ
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
Generic APIs producer

More Products from Cayman Pharma s.r.o (4)

  • CGMP Bimatoprost

    Product CGMP Bimatoprost

    Bimatoprost is a potent FP receptor agonist that finds clinical use as an ocular hypotensive agent for the treatment of glaucoma. The DMF is on file with the US FDA, Brazil, Canada and India.
  • CGMP Epoprostenol sodium salt

    Product CGMP Epoprostenol sodium salt

    Epoprostenol is a potent vasodilator and antiplatelet substance with a very short physiological half-life. It is used for the treatment of pulmonary hypertension. The DMF for Epoprostenol Sodium Salt is on file with the US FDA, Canada, Japan, Australia, Switzerland and most EU member states.
  • CGMP Cloprostenol sodium salt

    Product CGMP Cloprostenol sodium salt

    Cloprostenol sodium salt is used in veterinary medicine as a luteolytic agent for the induction of estrus and the treatment of reproductive disorders in cattle, swine, and horses. Cloprostenol sodium salt is manufactured at Cayman Pharma both in racemic form (CAS No.: 55028-72-3) and optically active form ...
  • CGMP Latanoprostene Bunod

    Product CGMP Latanoprostene Bunod

    Latanoprostene Bunod is a nitric oxide-donating FP receptor agonist; it can be used for the treatment of elevated intraocular pressure (IOP) in glaucoma. Latanoprostene Bunod is manufactured at Cayman Pharma, our Czech subsidiary. GMP material is available, and the DMF for Latanoprostene Bunod is available...

Cayman Pharma s.r.o resources (2)

  • News Cayman Chemical Receives CEP for Latanoprost API from EDQM

    ANN ARBOR, MI, SEPTEMBER 12, 2023—Cayman Chemical, a world leader in the manufacture of prostaglandins for both research use and as active pharmaceutical ingredients (APIs), has been granted a Certification of Suitability to the monographs of the European Pharmacopoeia (CEP) by the European Directorate for the Quality of Medicines and HealthCare (EDQM) for its latanoprost API, effective August 28th, 2023. Cayman Chemical is the first company in the USA to receive a CEP for latanoprost.
  • Brochure API Manufacturing

    Learn more about the importance of process understanding and Cayman's commercial API production